Chronic kidney disease cases have increased in the recent years in India. Early symptoms are often subtle, making it difficult to detect the disease. Most people end up with dialysis or transplant.

Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials. The drug, lorundrostat, was ...

Researchers advocate broader adoption of potassium-enriched salt to combat high stroke recurrence rates among stroke ...

AstraZeneca Pharma India has received approval to import and sell sodium zirconium cyclosilicate (Lokelma) for treating hyperkalemia in adults in India. The drug is indicated for the treatment of ...

Jodi Vance, a 20-year-old bodybuilder, died from heart complications caused by severe dehydration. This highlights the ...

Jodi Vance died of heart complications due to severe dehydration. The practice of extreme dehydration before competitions can ...

The Department of Medicine Nephrology Service at Womack Army Medical Center are pushing the limits of what can be done to ...

The following is a summary of “Hyperkalemia is associated with short- and mid-term mortalities in critically ill patients in ...

Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Researchers used data from the original study, which monitored blood pressure, stroke recurrence, mortality, and safety outcomes, including hyperkalemia risk. Urinary sodium/potassium excretion ...

Background: This study aims to evaluate the incidence of hyperkalemia and serum potassium levels associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT-2i), ...